As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, ...

Whether you're settling into your 60s or heading into your 90s, be careful when taking medicines, herbal preparations and ...

We still don’t know the full extent of layoffs at the FDA, though they are widespread. That could reduce oversight of the ...

The FDA was already understaffed and behind in inspections when the Trump administration began its layoffs. Here's what you ...

Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...

Attorney Kyle Diamantas is expected to be announced as the new deputy commissioner for human foods at the Food and Drug Administration following his predecessor’s resignation earlier this week, a ...

The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...

Dr. Tom Frieden, a former CDC director under President Barack Obama and the current president and CEO of the health advocacy ...

Morale is low at the FDA, which was hit with layoffs this week following RFK Jr.’s confirmation. Biopharma leaders and agency ...

"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency ...

A Food and Drug Administration division that went through a major reorganization to address concerns about food safety was ...

Woman,” “disabled” and “elderly” are reportedly on a list of terms that U.S. Food and Drug Administration scientists have ...